Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Matthias Pauschinger

Showing results (41-50 of 116) with videos related to

Pageof 12
Sort By:
Circulation|May 29, 2003
Interferon-beta treatment eliminates cardiotropic viruses and improves left ventricular function in patients with myocardial persistence of viral genomes and left ventricular dysfunctionUwe Kühl, Matthias Pauschinger, Peter Lothar Schwimmbeck, et al.
Cardiovascular Revascularization Medicine : Including Molecular Interventions|June 19, 2007
Mechanisms of late lumen loss after antiproliferative percutaneous coronary intervention using beta-irradiation in a porcine model of restenosisCarolin Deiner, Christoph Loddenkemper, Ursula Rauch, et al.
European Journal of Emergency Medicine : Official Journal of the European Society for Emergency Medicine|December 17, 2008
Prehospital versus periprocedural abciximab in ST-elevation myocardial infarction treated by percutaneous coronary interventionKlaus Pels, Joachim Schröder, Bernhard Witzenbichler, et al.
Clinical Interventions in Aging|February 15, 2018
Functionality and Outcome in Older Patients with Severe Aortic Stenosis (FOOPAS): an interdisciplinary study concept for a prospective trialFerdinand Vogt, Susanne Wicklein, Markus Gosch, et al.
Journal of the American College of Cardiology|September 20, 2014
Comprehensive prognosis assessment by CMR imaging after ST-segment elevation myocardial infarctionIngo Eitel, Suzanne de Waha, Jochen Wöhrle, et al.
Circulation|February 9, 2005
High prevalence of viral genomes and multiple viral infections in the myocardium of adults with "idiopathic" left ventricular dysfunctionUwe Kühl, Matthias Pauschinger, Michel Noutsias, et al.
European Journal of Pharmacology|May 14, 2004
Hemodynamic characterization of left ventricular function in experimental coxsackieviral myocarditis: effects of carvedilol and metoprololCarsten Tschöpe, Dirk Westermann, Paul Steendijk, et al.
Herzschrittmachertherapie & Elektrophysiologie|May 20, 2026
[Late complications after atrial fibrillation ablation : Diagnosis and management]Thomas Deneke, Kinan Kneizeh, Andrea Brinker-Paschke, et al.
Journal of Clinical Medicine|April 3, 2021
Comparison between Surgical Access and Percutaneous Closure Device in 787 Patients Undergoing Transcatheter Aortic Valve ReplacementDennis Eckner, Francesco Pollari, Giuseppe Santarpino, et al.
Journal of Cardiovascular Development and Disease|November 25, 2021
Differences in the Treatment of Acute Coronary Syndrome in the Pre-COVID and COVID Era: An Analysis from Two German High-Volume CentersDennis Eckner, Eva M Hofmann, Fadil Ademaj, et al.
Pageof 12

Showing results (41-50 of 116) with videos related to

Sort By:
Pageof 12
Circulation|May 29, 2003
Interferon-beta treatment eliminates cardiotropic viruses and improves left ventricular function in patients with myocardial persistence of viral genomes and left ventricular dysfunctionUwe Kühl, Matthias Pauschinger, Peter Lothar Schwimmbeck, et al.
Cardiovascular Revascularization Medicine : Including Molecular Interventions|June 19, 2007
Mechanisms of late lumen loss after antiproliferative percutaneous coronary intervention using beta-irradiation in a porcine model of restenosisCarolin Deiner, Christoph Loddenkemper, Ursula Rauch, et al.
European Journal of Emergency Medicine : Official Journal of the European Society for Emergency Medicine|December 17, 2008
Prehospital versus periprocedural abciximab in ST-elevation myocardial infarction treated by percutaneous coronary interventionKlaus Pels, Joachim Schröder, Bernhard Witzenbichler, et al.
Clinical Interventions in Aging|February 15, 2018
Functionality and Outcome in Older Patients with Severe Aortic Stenosis (FOOPAS): an interdisciplinary study concept for a prospective trialFerdinand Vogt, Susanne Wicklein, Markus Gosch, et al.
Journal of the American College of Cardiology|September 20, 2014
Comprehensive prognosis assessment by CMR imaging after ST-segment elevation myocardial infarctionIngo Eitel, Suzanne de Waha, Jochen Wöhrle, et al.
Circulation|February 9, 2005
High prevalence of viral genomes and multiple viral infections in the myocardium of adults with "idiopathic" left ventricular dysfunctionUwe Kühl, Matthias Pauschinger, Michel Noutsias, et al.
European Journal of Pharmacology|May 14, 2004
Hemodynamic characterization of left ventricular function in experimental coxsackieviral myocarditis: effects of carvedilol and metoprololCarsten Tschöpe, Dirk Westermann, Paul Steendijk, et al.
Herzschrittmachertherapie & Elektrophysiologie|May 20, 2026
[Late complications after atrial fibrillation ablation : Diagnosis and management]Thomas Deneke, Kinan Kneizeh, Andrea Brinker-Paschke, et al.
Journal of Clinical Medicine|April 3, 2021
Comparison between Surgical Access and Percutaneous Closure Device in 787 Patients Undergoing Transcatheter Aortic Valve ReplacementDennis Eckner, Francesco Pollari, Giuseppe Santarpino, et al.
Journal of Cardiovascular Development and Disease|November 25, 2021
Differences in the Treatment of Acute Coronary Syndrome in the Pre-COVID and COVID Era: An Analysis from Two German High-Volume CentersDennis Eckner, Eva M Hofmann, Fadil Ademaj, et al.
Pageof 12